Resources | Blog

The latest insights from our team.

Posts about


Kalderos favors action to protect hospitals from losing 340B eligibility

Kalderos supports HHS' move to rescind the FQHC "insulin rule"

With new ADR rule, 340B data transparency is more important than ever

2022 Annual Report

Conquering the “Great Unknown”

Our 2022 annual report takes aim at the gaps in knowledge, data and technology that create systemic challenges for all stakeholders who provide patients with life-saving and life-changing treatments.

Asset 9@2x

Additional assistance

Support Image


Get answers to all of your questions about Kalderos and Drug Discount Management.


Customer Support

Visit Kalderos’ help center for assistance with your Kalderos account.



Find out how we’re redefining how the business of healthcare performs.